CATALOGO DEI PRODOTTI DELLA RICERCA

BENEDETTI, MARIADONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.630
EU - Europa 4.403
AS - Asia 2.695
SA - Sud America 369
AF - Africa 47
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.569
RU - Federazione Russa 1.583
CN - Cina 1.145
GB - Regno Unito 970
SG - Singapore 965
SE - Svezia 390
IT - Italia 354
BR - Brasile 294
FR - Francia 257
HK - Hong Kong 247
FI - Finlandia 231
DE - Germania 209
IE - Irlanda 209
VN - Vietnam 124
UA - Ucraina 61
KR - Corea 43
CA - Canada 31
TR - Turchia 31
AR - Argentina 30
BE - Belgio 29
JP - Giappone 25
IN - India 22
PL - Polonia 21
MX - Messico 19
ZA - Sudafrica 17
ID - Indonesia 14
NL - Olanda 14
IR - Iran 12
PY - Paraguay 12
BD - Bangladesh 11
EC - Ecuador 11
ES - Italia 11
AT - Austria 10
CZ - Repubblica Ceca 10
IL - Israele 10
CL - Cile 9
AU - Australia 8
IQ - Iraq 8
MA - Marocco 7
UZ - Uzbekistan 7
CH - Svizzera 6
CO - Colombia 6
DK - Danimarca 6
EU - Europa 6
GR - Grecia 6
SA - Arabia Saudita 6
DO - Repubblica Dominicana 5
LT - Lituania 5
EG - Egitto 4
RO - Romania 4
BG - Bulgaria 3
DZ - Algeria 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
TN - Tunisia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SN - Senegal 2
TG - Togo 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 12.162
Salva come PNG Salva come JPEG
Città #
Southend 814
Chandler 611
Moscow 537
Dallas 442
Jacksonville 428
Singapore 428
Woodbridge 410
Ashburn 399
Ann Arbor 301
Hong Kong 244
Dublin 209
Houston 190
Beijing 179
New York 134
Verona 102
Wilmington 97
Lawrence 89
Princeton 89
Nanjing 85
Jinan 80
Hebei 74
Los Angeles 74
Helsinki 73
Shenyang 62
Tianjin 43
Buffalo 41
Munich 41
The Dalles 41
Haikou 40
Changsha 39
Boardman 37
Ningbo 37
Ho Chi Minh City 34
Columbus 33
Zhengzhou 31
Hanoi 30
Redondo Beach 30
São Paulo 30
Brussels 29
Milan 28
Taiyuan 28
Turku 28
Hangzhou 27
Lancaster 27
Washington 27
Nanchang 26
Taizhou 25
Council Bluffs 24
Fuzhou 24
Santa Clara 24
Sindelfingen 22
Stockholm 22
Tokyo 21
Redmond 20
Redwood City 20
Guangzhou 19
Istanbul 18
Jiaxing 18
Bologna 17
Brooklyn 17
Seattle 17
Norwalk 16
Warsaw 16
Atlanta 15
Auburn Hills 15
Poplar 15
Denver 14
Falls Church 14
Lanzhou 14
Belo Horizonte 12
Boston 12
Düsseldorf 12
Montreal 12
Seoul 12
Clearwater 11
Johannesburg 11
Chicago 10
Dong Ket 10
London 10
Olomouc 10
Orem 10
Phoenix 10
Riva 10
San Francisco 10
Kemerovo 9
Rome 9
Buenos Aires 8
Da Nang 8
Jakarta 8
Nuremberg 8
Amsterdam 7
Bolzano 7
Cleveland 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Manchester 7
Rio de Janeiro 7
Arco 6
Ardabil 6
Totale 7.585
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 214
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 204
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 200
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 194
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 194
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 189
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 185
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 183
Cognitive onset in multiple sclerosis 182
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 180
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 177
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 177
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 177
A case of acute fulminant multiple sclerosis treated with alemtuzumab 177
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 175
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 167
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 167
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 165
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 164
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 164
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 164
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 161
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 160
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 157
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 156
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 153
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 152
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 150
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 150
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 148
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 148
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 147
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 147
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 147
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 147
Epilepsy in multiple sclerosis: The role of temporal lobe damage 147
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 146
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 145
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 145
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 144
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 142
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 142
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 140
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 139
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 135
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 135
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 131
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 131
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 130
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 129
Epilessia ed imaging 127
Multifactorial etiological aspects of epilepsy 126
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 126
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 126
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 125
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 124
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 123
Short term prognosis of stroke in a clinical series of 94 patients 120
Azathioprine in multiple sclerosis 120
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 120
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 119
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 118
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 117
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 116
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 114
Long survival and clinical stability in Marburg's variant multiple sclerosis. 112
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 111
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 110
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 107
Prognostic factors of acute partial transverse myelitis. 106
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 104
Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy 104
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 104
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 103
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 101
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 100
Use of plasma levels for antiepileptic drug monitoring in clinical practice 99
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 97
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 97
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 96
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 94
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 92
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 87
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 84
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 82
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 77
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 77
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 75
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 74
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 72
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 71
Totale 12.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.046
article - articoli 39.660
book - libri 0
conference - conferenze 458
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 928
Totale 82.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021457 0 0 0 0 97 92 17 41 39 35 92 44
2021/2022938 85 350 12 122 19 23 10 54 26 18 51 168
2022/20231.607 109 195 140 290 126 364 12 114 176 11 49 21
2023/2024860 30 72 83 85 101 195 26 78 6 33 90 61
2024/20251.832 95 128 104 288 111 71 93 72 252 97 152 369
2025/20263.413 408 266 486 920 1.333 0 0 0 0 0 0 0
Totale 12.260